← Back to All Filings

Celestica Appoints Todd Ankenmann as CFO, Reports Initial Equity Holdings

Low SignificanceOctober 1, 2026 at 9:09:25 PM UTC

CELESTICA INC

$CLS3CIK: 0001030894

Subscribe to track CLS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Form 3 Initial Statement: Celestica Inc ($CLS) šŸ‘¤ Reporting Owner: Todd Ankenmann (Chief Financial Officer) šŸ“… Effective Date: October 1, 2026 šŸ’¼ Reported Holdings: • Restricted Share Units: 3,242 Common Shares underlying

  • 1,477 RSUs (Grant date: Feb 2, 2024)
  • 993 RSUs (Grant date: Feb 4, 2025)
  • 772 RSUs (Grant date: Feb 3, 2026) • Direct Common Stock: 0 shares šŸ“Š Significance: Low (Routine Initial Ownership Filing)

Comprehensive Analysis

Executive Summary

On October 1, 2026, Todd Ankenmann filed an initial Form 3 with the SEC following his appointment as Chief Financial Officer of Celestica Inc. (NYSE/TSX: CLS). As an initial statement of beneficial ownership, the filing reports existing equity awards and does not indicate any open-market purchases or sales.

Holdings Analysis

Mr. Ankenmann reported direct ownership of derivative securities consisting of three tranches of Restricted Share Units (RSUs), convertible 1-for-1 into Common Shares (or cash equivalent at holder election):

  • 1,477 RSUs from a grant dated February 2, 2024 (originally 4,430 RSUs vesting over three years).
  • 993 RSUs from a grant dated February 4, 2025 (originally 1,490 RSUs vesting over three years).
  • 772 RSUs from a grant dated February 3, 2026 (originally 772 RSUs vesting over three years).
  • Total Underlying Common Shares: 3,242 RSUs.

No directly owned Common Shares were reported at the time of filing.

Market and Trading Implications

This filing carries a Low trading significance, as it reflects standard disclosure requirements for newly appointed executive officers under Section 16(a) of the Securities Exchange Act of 1934. There are no immediate direct market transactions associated with this event.

Topics:#Celestica#CLS#Form3#InsiderTrading#CFO

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.